188 related articles for article (PubMed ID: 6470196)
1. Development of tolerance to the therapeutic effect of amantadine on akathisia.
Zubenko GS; Barreira P; Lipinski JF
J Clin Psychopharmacol; 1984 Aug; 4(4):218-20. PubMed ID: 6470196
[TBL] [Abstract][Full Text] [Related]
2. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
Keepers GA; Casey DE
Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
[No Abstract] [Full Text] [Related]
3. Propranolol in the treatment of neuroleptic-induced akathisia.
Lipinski JF; Zubenko GS; Cohen BM; Barreira PJ
Am J Psychiatry; 1984 Mar; 141(3):412-5. PubMed ID: 6142657
[TBL] [Abstract][Full Text] [Related]
4. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
5. Akathisia: an overlooked, distressing, but treatable condition.
Shen WW
J Nerv Ment Dis; 1981 Sep; 169(9):599-600. PubMed ID: 7276921
[TBL] [Abstract][Full Text] [Related]
6. Opioid responsiveness in patients with neuroleptic-induced akathisia.
Walters A; Hening W; Chokroverty S; Fahn S
Mov Disord; 1986; 1(2):119-27. PubMed ID: 2904116
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Ghadirian AM; Annable L; Bélanger MC; Chouinard G
J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute neuroleptic-induced movement disorders.
Tonda ME; Guthrie SK
Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
[TBL] [Abstract][Full Text] [Related]
9. [Extrapyramidal reactions and neuroleptic malignant syndrome].
Gómez EA
Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):281-6. PubMed ID: 6535382
[TBL] [Abstract][Full Text] [Related]
10. The effect of amantadine on neuroleptic-induced parkinsonism.
Rüther E; Fussmann-Hegewald M; Eben E
Act Nerv Super (Praha); 1973 May; 15(2):93. PubMed ID: 4148089
[No Abstract] [Full Text] [Related]
11. Efficacy of low-dose metoprolol in neuroleptic-induced akathisia.
Kim A; Adler L; Angrist B; Rotrosen J
J Clin Psychopharmacol; 1989 Aug; 9(4):294-6. PubMed ID: 2570088
[TBL] [Abstract][Full Text] [Related]
12. Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin.
Miller CH; Fleischhacker WW; Ehrmann H; Kane JM
Psychopharmacol Bull; 1990; 26(3):373-6. PubMed ID: 1980375
[TBL] [Abstract][Full Text] [Related]
13. Studies on the time course and efficacy of beta-blockers in neuroleptic-induced akathisia and the akathisia of idiopathic Parkinson's disease.
Adler LA; Angrist B; Weinreb H; Rotrosen J
Psychopharmacol Bull; 1991; 27(2):107-11. PubMed ID: 1681561
[TBL] [Abstract][Full Text] [Related]
14. Propranolol as a primary treatment of neuroleptic-induced akathisia.
Irwin M; Sullivan G; Van Putten T
Hillside J Clin Psychiatry; 1988; 10(2):244-50. PubMed ID: 2906317
[TBL] [Abstract][Full Text] [Related]
15. Withdrawal akathisia: case reports and a proposed classification of chronic akathisia.
Lang AE
Mov Disord; 1994 Mar; 9(2):188-92. PubMed ID: 8196681
[TBL] [Abstract][Full Text] [Related]
16. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-related akathisia.
Zubenko GS; Cohen BM; Lipinski JF
J Clin Psychopharmacol; 1987 Aug; 7(4):254-7. PubMed ID: 3624508
[TBL] [Abstract][Full Text] [Related]
18. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality.
Modestin J; Vogt Wehrli M; Stephan PL; Agarwalla P
Pharmacopsychiatry; 2009 Mar; 42(2):57-60. PubMed ID: 19308879
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
Ganzini L; Casey DE; Hoffman WF; McCall AL
Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
[TBL] [Abstract][Full Text] [Related]
20. Effect of amantadine (Viregyt-K) on extrapyramidal symptoms of parkinsonian patients.
Boczán G
Ther Hung; 1974; 22(4):147-53. PubMed ID: 4465958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
